Journals / Erciyes Medical Journal / 2019 / Cilt: 41 - Sayı: 2

Zinc, Vitamin D, and TSH Levels in Patients with Vitiligo

Pages
148–152
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Increased TSH levels were higher in patients with vitiligo with non-significantly higher anti-TPO AB as suggested to be related to autoimmune disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Vitiligo is an acquired depigmenting autoimmune disorder of the skin.
📊
Key Findings & Data:Materials and Methods: We recruited 98 patients with vitiligo and 98 age- and sex-matched healthy subjects visiting dermatology clinics during spring and summer 2017.
💡
Conclusion & Impact:Increased TSH levels were higher in patients with vitiligo with non-significantly higher anti-TPO AB as suggested to be related to autoimmune disease.
🔬Design:Research Article
📍Scope:2017 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: Vitiligo is an acquired depigmenting autoimmune disorder of the skin. The disease association with autoimmune diseases, such as thyroid diseases, has been reported. Previous studies among patients with vitiligo have suggested possible correlation between zinc and vitamin D levels with conflicting results. Here we compared the thyroid hormones, zinc, and vitamin D levels in patients with vitiligo with normal healthy subjects. Materials and Methods: We recruited 98 patients with vitiligo and 98 age- and sex-matched healthy subjects visiting dermatology clinics during spring and summer 2017. Serum zinc and vitamin D levels as well as thyroid stimulating hormone (TSH) and thyroid peroxidase antibody (anti-TPO) were measured and compared between groups. Results: Patients with vitiligo had significantly lower zinc (p=0.01) and higher anti-TPO levels (p=0.02) with no difference in vitamin D (p=0.73) and TSH levels (p=0.31). Patients with vitiligo had also significantly higher rate of increased TSH (p=0.02) and positive anti-TPO (p=0.01). We observed no significant correlation between serum levels of vitamin D, zinc, and TSH with age, gender, and disease duration in patients with vitiligo. Conclusion: Patients with vitiligo, compared to healthy subjects, had lower serum zinc levels, but not vitamin D levels. Increased TSH levels were higher in patients with vitiligo with non-significantly higher anti-TPO AB as suggested to be related to autoimmune disease.

🔖

Cite This Article

SANIEE, S., ZARE, A. G., RADMEHR, A. (2019). Zinc, Vitamin D, and TSH Levels in Patients with Vitiligo. Erciyes Medical Journal, Cilt: 41 - Sayı: 2, 148–152. https://ajindex.com/articles/223461

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Yang Y, Huang G, Yan X, Qing Z. Clinical Analysis of Thyroglobulin Antibody and Thyroid Peroxidase Antibody and their Association with Vitiligo. Indian J Dermatol 2014; 59(4): 357–60.[CrossRef] Ezzedine K, Sheth V, Rodrigues M, Eleftheriadou V, Harris JE, Hamzavi IH, et al. Vitiligo is not a cosmetic disease. J Am Acad Dermatol 2015; 73(5): 883–5. [CrossRef] Doss RW, El-Rifaie AA, Gohary YM, Rashed LA. Vitamin D Receptor Expression in Vitiligo. Indian J Dermatol 2015; 60(6): 544–8. [CrossRef] Upala S, Sanguankeo A. Low 25-hydroxyvitamin D levels are associated with vitiligo: a systematic review and meta-analysis. Photodermatol Photoimmunol Photomed 2016; 32(4): 181–90. [CrossRef] Mirnezami M, Rahimi H. Serum Zinc Level in Vitiligo: A Case-control Study. Indian J Dermatol 2018; 63(3): 227–30
  2. Zhang JZ, Wang M, Ding Y, Gao F, Feng YY, Yakeya B, et al. Vitamin D receptor gene polymorphism, serum 25-hydroxyvitamin D levels, and risk of vitiligo: A meta-analysis. Medicine (Baltimore) 2018; 97(29): e11506. [CrossRef] Gopal KV, Rao GR, Kumar YH. Increased prevalence of thyroid dysfunction and diabetes mellitus in Indian vitiligo patients: A case-control study. Indian Dermatol Online J 2014; 5(4): 456–60. [CrossRef] Colucci R, Dragoni F, Moretti S. Oxidative stress and immune system in vitiligo and thyroid diseases. Oxid Med Cell Longev 2015; 2015: 631927. [CrossRef] Elbuluk N, Ezzedine K. Quality of Life, Burden of Disease, Co-morbidities, and Systemic Effects in Vitiligo Patients. Dermatol Clin 2017; 35(2): 117–28. [CrossRef] Vachiramon V, Harnchoowong S, Onprasert W, Chanprapaph K. Prevalence of Thyroid Abnormalities in Thai Patients with Vitiligo. Biomed Res Int 2017; 2017: 7502935. [CrossRef] Karagüzel G, Sakarya NP, Bahadır S, Yaman S, Ökten A.Vitamin D status and the effects of oral vitamin D treatment in children with vitiligo: A prospective study. - Clin Nutr ESPEN 2016; 15: 28–31.
  3. Cohen BE, Elbuluk N, Mu EW, Orlow SJ. Alternative Systemic Treatments for Vitiligo: A Review. Am J Clin Dermatol 2015; 16(6): 463– 74. [CrossRef] Mogaddam MR, Ardabili NS, Maleki N, Chinifroush MM, Fard EM. Evaluation of the serum zinc level in patients with vitiligo. Postepy Dermatol Alergol 2017; 34(2): 116–9. [CrossRef] Bagherani N, Yaghoobi R, Omidian M. Hypothesis: zinc can be effective in treatment of vitiligo. Indian J Dermatol 2011; 56(5): 480–4.
  4. Karagün E, Ergin C, Baysak S, Erden G, Aktaş H, Ekiz Ö. The role of serum vitamin D levels in vitiligo. Postepy Dermatol Alerg